COMMUNIQUÉS West-GlobeNewswire

DiamiR Announces Publication of Data on microRNA Biomarkers for Neurodegenerative Diseases in Alzheimer’s Research & Therapy

14/11/2017 - 12:02

MONMOUTH JUNCTION, N.J., Nov. 14, 2017 (GLOBE NEWSWIRE) -- DiamiR, a developer of innovative minimally invasive diagnostic tests for neurodegenerative and other diseases, announced today the publication of "Circulating [...]

BioNovelus agrees to Co-Directorship and advisory with Meroe Capital Group Ltd.

14/11/2017 - 12:00

FOR IMMEDIATE RELEASE — Phoenix, Nov. 14, 2017 (GLOBE NEWSWIRE) -- — BioNovelus (ONOV) has today announced the retention of New York-based Meroe Capital Group Ltd. In the structure of the deal, BioNovelus will become a [...]

Recruitment completed in trial to evaluate the optimal dosing frequency for Zealand's long-acting GLP-2 analog glepaglutide

14/11/2017 - 08:37

Press Release- No. 11/2017 Recruitment completed in trial to evaluate the optimal dosing frequency for Zealand's long-acting GLP-2 analog glepaglutide All 75 subjects dosed with glepaglutide in the clinical trial The [...]

Early close of offering of shares in Orphazyme

14/11/2017 - 08:31

Company announcement Orphazyme A/S No. 3/2017 Ole Maaløes Vej 3 DK-2200 Copenhagen N www.orphazyme.com Company Registration No. 32266355 14 November 2017 NOT FOR RELEASE OR DISTRIBUTION OR PUBLICATION IN WHOLE OR IN [...]

Novartis presents new data at SABCS across broad range of breast cancer patient populations, combination treatments and lines of therapy

14/11/2017 - 07:16

Presentation of results from the Kisqali ® (ribociclib) MONALEESA-7 Phase III trial exclusively studying premenopausal women with HR+/HER2- advanced breast cancer New MONALEESA-2 analyses focused on quality of life, [...]

New data reinforces clinical basis for switching to Sandoz biosimilar medicines

14/11/2017 - 07:11

Sandoz strengthens position as global leader in biosimilars with new immunology data from four clinical studies for proposed biosimilars adalimumab and rituximab Efficacy and safety of biosimilar adalimumab and safety [...]

Targovax to present at upcoming investor conferences

14/11/2017 - 07:01

Oslo, Norway, 14 November 2017 - Targovax ASA (OSE: TRVX), a clinical stage company focused on developing immuno-oncology therapies to target solid tumors, announces that members of its senior management will present at [...]

Tel Aviv District Court Ordered MediWound to Purchase Approximately $1.5 Million of PolyHeal Shares; MediWound Weighing an Appeal

14/11/2017 - 03:33

YAVNE, Israel, Nov. 13, 2017 (GLOBE NEWSWIRE) -- MediWound Ltd. (NASDAQ: MDWD ), a fully-integrated biopharmaceutical company specializing in innovative therapies to address unmet needs in severe burn and wound [...]

MolecularMD to Implement Promega’s Microsatellite Instability (MSI) Technology for Immuno-Oncology Applications

14/11/2017 - 02:00

PORTLAND, Ore. and CAMBRIDGE, Mass., Nov. 13, 2017 (GLOBE NEWSWIRE) -- MolecularMD announces that it has now become a Preferred Provider of Promega’s Microsatellite Instability (MSI) v1.2 Analysis System. MolecularMD [...]

CORRECTING and REPLACING -- Celsion Files Immunotherapy Clinical Protocol for the Evaluation of GEN-1 to Treat Newly Diagnosed Ovarian Cancer

14/11/2017 - 01:23

Expert Advisory Board Endorses Randomized Phase I/II Trial in Newly Diagnosed Stage III and IV Ovarian Cancer GEN-1 Immunotherapy to Enter Phase I/II Clinical Study in the First Half of 2018 Following a Phase IB Trial [...]

MyoKardia Presents Data from Study of Machine Learning Algorithm Intended to Identify Obstructive Hypertrophic Cardiomyopathy Using a Wearable Biosensor

14/11/2017 - 01:15

SOUTH SAN FRANCISCO, Calif., Nov. 13, 2017 (GLOBE NEWSWIRE) -- MyoKardia, Inc. (Nasdaq: MYOK ), a clinical-stage biopharmaceutical company pioneering a precision medicine approach for the treatment of heritable [...]

Arbutus’ LNP Licensee Alnylam Receives Accelerated Assessment of Patisiran from European Medicines Agency (EMA)

13/11/2017 - 23:22

VANCOUVER, British Columbia and WARMINSTER, Pa., Nov. 13, 2017 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq: ABUS ), an industry-leading Hepatitis B Virus (HBV) therapeutic solutions company, announced [...]

Celsion Files Immunotherapy Clinical Protocol for the Evaluation of GEN-1 to Treat Newly Diagnosed Ovarian Cancer

13/11/2017 - 23:15

Expert Advisory Board Endorses Randomized Phase I/II Trial in Newly Diagnosed Stage III and IV Ovarian Cancer GEN-1 Immunotherapy to Enter Phase I/II Clinical Study in the First Half of 2018 Following a Phase IB Trial [...]

Canada House Wellness Group provides Bi-Weekly Update on Status of Management Cease Trade Order

13/11/2017 - 22:57

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES TORONTO, Nov. 13, 2017 (GLOBE NEWSWIRE) -- Canada House Wellness Group Inc. (CSE:CHV) (“ Canada House ” or the “ Company ”) wishes to [...]

OnePoint Patient Care and Hospice by the Bay Partner to Provide Dedicated Hospice Pharmacy Services in Northern California

13/11/2017 - 22:56

MORTON GROVE, Ill., Nov. 13, 2017 (GLOBE NEWSWIRE) -- OnePoint Patient Care, the leader in national hospice PBM and pharmacy services, announced its partnership with Hospice by the Bay, a leading not-for-profit hospice [...]

Royal Adelaide Hospital goes live with Allscripts EHR solution

13/11/2017 - 22:30

ADELAIDE, Australia, Nov. 13, 2017 (GLOBE NEWSWIRE) -- Allscripts (NASDAQ: MDRX ) is in partnership with South Australia Health to deliver the Allscripts Sunrise™ product suite across the state of South Australia. The [...]

Clearside Biomedical, Inc. to Participate in Stifel 2017 Healthcare Conference

13/11/2017 - 22:30

ALPHARETTA, Ga., Nov. 13, 2017 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (NASDAQ: CLSD ), a late-stage clinical biopharmaceutical company developing first-in-class drug therapies to treat back-of-the-eye diseases, [...]

Royal Adelaide Hospital goes live with Allscripts EHR solution

13/11/2017 - 22:30

ADELAIDE, Australia, Nov. 13, 2017 (GLOBE NEWSWIRE) -- Allscripts (NASDAQ: MDRX ) is in partnership with South Australia Health to deliver the Allscripts Sunrise™ product suite across the state of South Australia. The [...]

Vascepa® (Icosapent Ethyl) Showed Reductions in Potentially Atherogenic Lipid and Inflammatory Markers in Statin Treated Patients With Persistent High Triglycerides and Chronic Kidney Disease

13/11/2017 - 22:30

BEDMINSTER, N.J. and DUBLIN, Ireland, Nov. 13, 2017 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ: AMRN ), a biopharmaceutical company focused on the commercialization and development of therapeutics to improve [...]